| Autor: |
Christopher W Teshima, Adrienne Thompson, LeRose Dhanoa, Levinus A Dieleman, Richard N Fedorak |
| Jazyk: |
angličtina |
| Rok vydání: |
2009 |
| Předmět: |
|
| Zdroj: |
Canadian Journal of Gastroenterology, Vol 23, Iss 5, Pp 348-352 (2009) |
| Druh dokumentu: |
article |
| ISSN: |
0835-7900 |
| DOI: |
10.1155/2009/180840 |
| Popis: |
BACKGROUND: Infliximab’s efficacy in the induction and maintenance of remission in luminal Crohn’s disease has been confirmed by randomized, controlled trials. Less clearly described are long-term outcomes in the clinical practice setting since the establishment of regularly scheduled, every eight-week maintenance infliximab infusions. Existing reports describing clinical practice outcomes are limited by short durations of follow-up or by the use of episodic dosing, or focus on safety data rather than clinical outcomes. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
